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Summary:
Spina bi!da is the most common neural tube defect (NTD) and 
is caused by an interaction of genetic and environmental factors. 
The congenital condition results from the failure of closure of the 
caudal neural tube and can led to a variety of complications. Current 
prevention and management interventions include taking folic acid 
supplements and undergoing operation before or a"er birth. The 
compulsory forti!cation of #our with folic acid has been successful 
in countries such as the USA, where studies have found that the 
prevalence of spina bi!da declined by 31% since forti!cation was 
introduced. Despite the evidence to support the legislation, there are 
many concerns regarding folic acid forti!cation. These include certain 
ethical considerations regarding the feelings of those already living with 
NTDs as well as a potentially increased risk of cancer due to excess folic 
acid in the diet. 
Relevance:
The British Government has recently announced plans to discuss the 
mandatory forti!cation of #our with folic acid. This is in response to 
the establishment of a causal link between NTDs such as spina bi!da 
and low folic acid levels in mothers during the embryonic stage of 
pregnancy. Evidence suggests that a diet containing folic acid reduces 
the risk of spina bi!da in o$spring by up to 70%.
Take Home Messages:
Further research is needed to explore the long-term e$ects of increased 
folic acid in the diet; however, it appears as though the evidence for the 
mandatory forti!cation of #our with regards to a signi!cant reduction 
in the risk of developing NTDs such as spina bi!da outweigh potential 
risks. 
The British Student Doctor, 2020:4(1):45-49
doi: 10.18573/bsdj.77
Re#ections
Ɠѵ
bsdj.org.uk
In November 2018, the British Government announced plans to 
consult on the mandatory forti!cation of #our with folic acid in 
a bid to reduce the incidence of neural tube defects (NTDs). The 
causal link between NTDs (such as spina bi!da and anencephaly) 
and low folic acid levels in pregnant women was established in 
1991 through trials conducted by the U.S. Department of Health 
and Human Services. (1) 26 years of subsequent pressure from 
independent scientists, charities and the Scienti!c Advisory 
Committee on Nutrition forced the government to discuss the 
introduction of this new regulation. The forti!cation of #our 
with folic acid is generally thought to be bene!cial by the medical 
community, including The Royal College of Obstetricians and 
Gynaecologists. (2) 
Between 1991 to 2012, the prevalence of pregnancy complicated 
by NTDs in the UK was 1.28 (95% CI 1.24 to 1.31) per 1000 total 
births, whereas NTD live births was only 0.20 per 1000 live births. 
However, there is evidence to suggest that had forti!cation been 
implemented at the level adopted by other countries (such as the 
USA) between 1998 to 2012, there would have been an estimated 
21% reduction in the prevalence of NTDs in the UK. (3) Despite 
the evidence in favour of forti!cation, potential concerns have 
been raised, which has delayed the process of implementing the 
public health measure. This paper aims to provide a background on 
spina bi!da before discussing the advantages and disadvantages of 
fortifying #our with folic acid. 
NTDs are a spectrum of disorders characterised by the abnormal 
development of the brain or spinal cord. Spina bi!da is the most 
common NTD. The term spina bi!da is derived from Latin for 
‘split spine’ and the earliest known cases were two mummi!ed 
newborns found in King Tutankhamen’s tomb. (4) Spina bi!da is a 
multifactorial condition, caused by both genetic and environmental 
factors. (5) One of the genes most commonly associated with spina 
bi!da is the MTHFR gene, which codes for an enzyme involved 
in processing folic acid, which is needed convert homocysteine 
to methionine. (6) It is thought that the failure to convert 
homocysteine leads to NTDs. Other risk factors include maternal 
diabetes, obesity (7) and exposure to teratogenic medications, such 
as the antiepileptic sodium valproate. (8) 
Spina bi!da results from the failure of closure of the caudal neural 
tube. In normal embryology, neural tube closure occurs from the 
23rd (rostrally) to the 27th (caudally) day a"er fertilization. (9) 
However, in spina bi!da the vertebrae and membranes surrounding 
the spinal cord at the lumbosacral region fail to fuse.
There are three classi!cations of spina bi!da: occulta, meningocele 
and myelomeningocele. Spina bi!da occulta, known as ‘hidden’ 
spina bi!da, is the mildest and most common form. It is believed 
that up to 10% of the British population have spina bi!da occulta. 
(10) Formal diagnosis is through plain !lm radiograph, though 
newborns o"en have a visible indication above the spinal defect 
such as an abnormal tu" of hair, dimpling or a birthmark. (11) 
There are no consequences of spina bi!da occulta and so no 
treatment is required. In meningocele, the meninges herniate 
through the vertebral opening, forming a #uid-!lled sac. This cyst 
does not contain the spinal cord, so nerve damage is unlikely but 
when it does occur, patients o"en experience bowel incontinence 
as the only resulting symptom. (12) The most severe form of 
spina bi!da is myelomeningocele, in which both the meninges 
and spinal cord herniate through a gap in the vertebral arch. This 
results in a variety of complications such as lower limb motor and 
sensory dysfunction, urinary and bowel incontinence, orthopaedic 
deformities, hydrocephalus and Chiari II malformation (a 
downward displacement of cerebellar tonsils through the foramen 
magnum). (10, 12) Figure 1 summarises the three types of spina 
bi!da.
Figure 1: The three types of spina bi!da 
Spina bi!da meningocele and myelomeningocele are surgically 
treated either by intrauterine repair surgery, or surgery within the 
!rst few days a"er birth. The herniated meningeal sac is excised and 
in myelomeningocele, the spinal cord is returned to the spinal canal, 
before the surrounding dura mater is closed over the defect. (13) 
Surgical correction is required to prevent neurological infections as 
well as injury to the exposed spinal cord and nerves.
Folic acid is required for haematopoiesis, DNA synthesis and 
neural development. (14) In a bid to reduce the risk of spina 
bi!da, expectant mothers are currently advised to take folic acid 
supplements. Daily recommendations for folic acid are usually 
200µg for anyone over the age of 11 years, but 300µg plus a 400µg 
supplement of folic acid during the !rst 12 weeks of pregnancy 
for expectant mothers. (15) Evidence suggests that taking these 
supplements reduces the risk of a mother giving birth to a child 
with spina bi!da by up to 70%. (16)
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Without supplementation, folic acid can only be obtained via 
the consumption of natural folic acid-containing foods (such as 
legumes, asparagus, eggs, potatoes, brussel sprouts and baked 
beans). (17) Large portions of these foods would be needed to 
reach a daily intake of 400µg, which is o"en too di%cult for many 
women to achieve. Moreover, adequate folic acid levels are most 
important during the embryonic stage of pregnancy (as this is when 
the neural tube develops), which is also when many women do not 
yet know that they are pregnant. Forti!cation could boost folic acid 
levels during the !rst trimester of pregnancy in the bodies of those 
most at risk from de!ciency and therefore at risk of having a child 
with a NTD. (18) Women at risk include those from lower socio-
economic groups, younger mothers and those with unplanned 
pregnancies. 
Food forti!cation has previously been implemented in the UK. 
Under the UK Bread and Flour Regulations 1998, industry is 
currently required to add iron, calcium, thiamine and niacin to 
all wheat #our and white bread in a bid to reduce de!ciencies. 
(19) Moreover, the compulsory forti!cation of #our with folic 
acid has been successful in countries such as Chile and the Unites 
States. Since introduced in 1998, a US study reported that within 
two years, the prevalence of spina bi!da declined by 31% and the 
incidence of anencephaly by 16%, exemplifying the bene!ts. (20)
To summarise, the main advantage of fortifying #our is that the 
move would reduce the prevalence of folic acid de!ciency. This 
would therefore reduce the incidence of folic acid-dependent 
conditions such as NTDs. Despite this advantage, there are several 
concerns, which have contributed to the UK government’s delay 
in employing the change. The forti!cation of #our is essentially a 
public health intervention, which means that its implementation 
is likely to achieve outcomes at a population level but is also likely 
to fail to meet the immediate needs of individuals. Not all women 
consume the same levels of folic acid, so forti!cation may not 
be fully e$ective and could even result in some consuming too 
much folic acid in their diets. Long term consequences of a high 
intake (>1000µg per day) manifest as abdominal cramps, diarrhoea, 
irritability, nausea and skin reactions. (21) One could argue that the 
government should focus on providing health advice and treatment 
tailored to individual needs to avoid such consequences whilst still 
preventing a woman’s pregnancy being complicated by a NTD, 
rather than via a non-speci!c public health measure. 
There are also ethical considerations that the government will 
have to address when trying to eradicate NTDs; patients who 
su$er a signi!cant disability due to a NTD may feel ashamed and 
unwanted by society and would rather the government concentrate 
on managing the needs of existing people a$ected by NTDs more 
e$ectively. Since folic acid is only one of the contributing factors 
to the development of spina bi!da, forti!cation will not completely 
eradicate the disease. (22) Therefore, one could argue that it could 
be more cost e$ective to spend on improving the current treatment 
accessed by those su$ering with spina bi!da, whilst also increasing 
awareness and reducing the discrimination faced by those living 
with NTDs, in order to improve the quality of their lives.
Another concern with such a large-scale public intervention is 
the lack of population-based evidence regarding the long-term 
e$ects of increased folic acid intake. The US was the !rst country 
to introduce mandatory folic acid forti!cation in 1998, (16) before 
which there are no national records lasting over 20 years about 
the impact of folic acid consumption on the population. Further 
research is needed to assess the long-term e$ects of folic acid.  
Furthermore, high folic acid diets are thought to be associated with 
an increased risk of cancer. A meta-analysis of 19 studies found an 
increased risk of cancer overall (RR 1.07, 95% CI 1.00 to 1.14) in 
subjects taking ≥0.4 mg folic acid supplements per day. The risk 
of prostate cancer was signi!cantly raised (RR 1.24, 95% CI 1.03 
to 1.49). (23) Since the daily folic acid recommendations for most 
of the public are 0.2mg per day, yet the study observed increased 
cancer incidence from double that amount, it is possible that there 
may be a link between cancer and high folic acid intake. 
Finally, there are worries that a high intake of folic acid from 
forti!ed food could mask macrocytic anaemia which is an 
important diagnostic sign of vitamin B12 de!ciency. (24) As well as 
haematopoiesis, B12 is essential in brain and nervous function, and 
therefore de!ciency can lead to neurological disturbances such as 
Alzheimer’s disease. (25) 
Currently, the government have only announced their plans to 
begin formal talks for mandatory forti!cation of #our with folic 
acid. Discussions regarding how this will be implemented, when 
and how the move will be regulated are yet to take place but are 
soon expected due to pressure from several MPs, independent 
researchers and NHS advisory bodies. (26) Moreover, further 
research is needed to explore the long-term e$ects of increased folic 
acid in the diet, especially its potential link to cancer. However, for 
now, it appears that the evidence for the mandatory forti!cation 
of #our leading to a signi!cant reduction in the risk of developing 
NTDs outweigh the potential risks. Therefore, medical students 
and clinicians alike should continue to educate and advise the public 
about folic acid’s health bene!ts, especially for expectant mothers.
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